Abstract
Pathogenic yeasts of the genus Candida represent a serious threat to immunocompromised individuals. Soluble secreted aspartic proteinases produced by these opportunistic pathogens have been studied as one of the virulence factors and potential target for therapeutic intervention. Several structures of these enzymes in complex with inhibitors have been published; however, only a limited number of novel inhibitory compounds have been reported recently. Other members of aspartic proteinase family received less attention, although they are important for Candida survival in the host environment. Proteinases attached to the cell surface by GPI-anchor, as well as vacuolar aspartic proteinases may thus become promising therapeutic targets. This review summarizes the data available on less studied aspartic proteinases of C. albicans, and poses the question, whether the knowledge of vacuolar and GPI-anchored aspartic proteinases from Saccharomyces cerevisiae can inspire design of compounds inhibiting these types of enzymes in the pathogenic yeasts.
Keywords: Aspartic proteinase, Candida spp, GPI-anchored protein, IA3, Saccharomyces cerevisiae, secreted proteinase, vacuole, virulence factors, antimycotics, mycoses
Current Enzyme Inhibition
Title: Intracellular and Extracellular Aspartic Proteinases of Pathogenic Candida Species: Can their Inhibitors be Further Developed?
Volume: 7 Issue: 2
Author(s): Vaclava Bauerova, Zuzana Vinterova, Iva Pichova and Olga Hruskova-Heidingsfeldova
Affiliation:
Keywords: Aspartic proteinase, Candida spp, GPI-anchored protein, IA3, Saccharomyces cerevisiae, secreted proteinase, vacuole, virulence factors, antimycotics, mycoses
Abstract: Pathogenic yeasts of the genus Candida represent a serious threat to immunocompromised individuals. Soluble secreted aspartic proteinases produced by these opportunistic pathogens have been studied as one of the virulence factors and potential target for therapeutic intervention. Several structures of these enzymes in complex with inhibitors have been published; however, only a limited number of novel inhibitory compounds have been reported recently. Other members of aspartic proteinase family received less attention, although they are important for Candida survival in the host environment. Proteinases attached to the cell surface by GPI-anchor, as well as vacuolar aspartic proteinases may thus become promising therapeutic targets. This review summarizes the data available on less studied aspartic proteinases of C. albicans, and poses the question, whether the knowledge of vacuolar and GPI-anchored aspartic proteinases from Saccharomyces cerevisiae can inspire design of compounds inhibiting these types of enzymes in the pathogenic yeasts.
Export Options
About this article
Cite this article as:
Bauerova Vaclava, Vinterova Zuzana, Pichova Iva and Hruskova-Heidingsfeldova Olga, Intracellular and Extracellular Aspartic Proteinases of Pathogenic Candida Species: Can their Inhibitors be Further Developed?, Current Enzyme Inhibition 2011; 7 (2) . https://dx.doi.org/10.2174/157340811796575263
DOI https://dx.doi.org/10.2174/157340811796575263 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Photo-triggered Drug Delivery Systems for Neuron-related Applications
Current Medicinal Chemistry Homocysteine, Cardiovascular Inflammation, and Myocardial Remodeling
Cardiovascular & Hematological Disorders-Drug Targets Intracranial Atherosclerotic Stenosis is Related to Post-stroke Cognitive Impairment: A Cross-sectional Study of Minor Stroke
Current Alzheimer Research Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy
Current Neuropharmacology Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Alteration of the Beta-Adrenergic Signaling Pathway in Human Heart Failure
Current Pharmaceutical Biotechnology Effect of Administration of Nandrolone Decanoate upon Aldosterone Concentration and Serum Na+/K+ Levels in Albino Mice
Cardiovascular & Hematological Agents in Medicinal Chemistry Epicardial Adipose Tissue As New Cardio-Metabolic Risk Marker and Potential Therapeutic Target in the Metabolic Syndrome
Current Pharmaceutical Design Attitudinal & Knowledge Barriers Towards Effective Pain Assessment & Management in Dementia: A Narrative Synthesis
Current Alzheimer Research Hypoxia-inducible Factor (HIF) in Hormone Signaling During Health and Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Proteins in Saccharides Matrices and the Trehalose Peculiarity: Biochemical and Biophysical Properties
Current Organic Chemistry Molecular Imaging Strategies for In Vivo Tracking of MicroRNAs: A Comprehensive Review
Current Medicinal Chemistry Aβ Produced as a Fusion to Maltose Binding Protein Can Be Readily Purified and Stably Associates with Copper and Zinc
Protein & Peptide Letters Diseases Associated with General Amino Acid Transporters of the Solute Carrier 6 Family (SLC6)
Current Molecular Pharmacology Synthesis of New Arylidene 2,5-Diketopiperazines and Evaluation of their Anti-Acetylcholinesterase, Anti-xanthine Oxidase, Anti-diabetic and Cytotoxic Activities
Medicinal Chemistry Regulation Of In Vitro Fibril Formation Of Synuclein Mutant Proteins By Hsp104p
Protein & Peptide Letters Reflections on MicroRNAs in Chronic Pulmonary Disease: Looking into the miR-ror and Crystal Ball
Inflammation & Allergy - Drug Targets (Discontinued) Impact and Therapeutic Potential of PPARs in Alzheimers Disease
Current Neuropharmacology Novel Insight into Differential Gene Expression and Clinical Significance of Dopamine Receptors, COMT, and IL6 in BPH and Prostate Cancer
Current Molecular Medicine Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis
Recent Patents on CNS Drug Discovery (Discontinued)